GSA Capital Partners’s Caribou Biosciences CRBU Stock Holding History

GSA Capital Partners’s Portfolio CRBU Stock Details CRBU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$816K	Sell	463,416 -17,308	-4%	-$34.2K	0.05%	638
2026 Q1	$913K	Buy	480,724 +109,352	+29%	+$188K	0.06%	535
2025 Q4	$590K	Buy	+371,372	New	+$779K	0.05%	705
2025 Q3	–	Sell	-166,396	Closed	-$210K	–	1716
2025 Q2	$210K	Buy	166,396 +148,791	+845%	+$146K	0.01%	1485
2025 Q1	$16K	Buy	+17,605	New	+$22.9K	﹤0.01%	1588
2023 Q4	–	Sell	-10,734	Closed	-$51K	–	1551
2023 Q3	$51K	Buy	+10,734	New	+$66.6K	﹤0.01%	1415
2022 Q3	–	Sell	-14,917	Closed	-$81K	–	1571
2022 Q2	$81K	Sell	14,917 -10,104	-40%	-$77.2K	0.01%	1246
2022 Q1	$230K	Buy	+25,021	New	+$264K	0.03%	1084

Other funds holding CRBU

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Pfizer New York $170M AUM 191.09% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

GSA Capital Partners's CRBU Position: Q2 2026 in Review

GSA Capital Partners reduced its Caribou Biosciences (CRBU) stake by 3.6% in Q2 2026, selling an estimated $34.2K and leaving 463,416 shares worth $816K. The position accounts for 0.05% of the portfolio, ranked #638.

GSA Capital Partners first reported a position in CRBU in Q1 2022 and has held it in 8 quarters since. The position peaked at $913K in Q1 2026. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

GSA Capital Partners held 463,416 shares of Caribou Biosciences worth $816K as of Q2 2026.
GSA Capital Partners sold 17,308 Caribou Biosciences shares in Q2 2026, an estimated $34.2K.
Caribou Biosciences made up 0.05% of GSA Capital Partners's portfolio in Q2 2026, its #638 holding.
GSA Capital Partners first reported a position in Caribou Biosciences in Q1 2022 and has held it in 8 quarters since.
GSA Capital Partners's Caribou Biosciences position peaked at $913K in Q1 2026.
137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.